Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Obio Technology (Group) Days Payable Chart
SHSE:688238 vs VRTX, REGN, RVMD: Days Payable Comparison
For the Biotechnology subindustry, Shanghai Obio Technology (Group)'s Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Shanghai Obio Technology (Group) Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Shanghai Obio Technology (Group)'s Days Payable distribution charts can be found below:
* The bar in red indicates where Shanghai Obio Technology (Group)'s Days Payable falls into.
Shanghai Obio Technology (Group) Days Payable Calculation
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Shanghai Obio Technology (Group) (SHSE:688238) has a Days Payable of 85.56 as of Jun. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Obio Technology (Group) and its competitors. This is 61% below median its historical median of 220.06. Over the past decade, Shanghai Obio Technology (Group)'s Days Payable has ranged from 96.00 to 413.24. According to the industry distribution chart, Shanghai Obio Technology (Group) ranks #362 out of 708 companies in the Biotechnology industry, placing it in the top 51.1%.
Is Shanghai Obio Technology (Group)'s Days Payable too high?
Shanghai Obio Technology (Group)'s current Days Payable of 85.56 is 61% below median its 10-year median of 220.06. Over the past 10 years, this metric has ranged from a low of 96.00 to a high of 413.24. The Biotechnology industry median Days Payable is 111.17. Shanghai Obio Technology (Group)'s value of 85.56 is 23% below this industry median. Based on the distribution chart, Shanghai Obio Technology (Group) ranks #362 out of 708 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Shanghai Obio Technology (Group) has a GF Score™ of 70/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Shanghai Obio Technology (Group)'s Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Shanghai Obio Technology (Group) ranks #362 out of 708 companies for Days Payable. This places Shanghai Obio Technology (Group) in the lower half of its industry. The industry median Days Payable is 111.17. Shanghai Obio Technology (Group)'s value of 85.56 is 23% below this benchmark. Historically, Shanghai Obio Technology (Group)'s own Days Payable has ranged from 96.00 to 413.24 over the past decade. While the company's 10-year median is 220.06 vs. the industry median of 111.17, Shanghai Obio Technology (Group) has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 111.17, based on 708 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Shanghai Obio Technology (Group)'s current Days Payable of 85.56 is 23% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Shanghai Obio Technology (Group) and its competitors. For the Biotechnology industry, the median Days Payable is 111.17 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Shanghai Obio Technology (Group)'s current Days Payable is 85.56, which is 61% below median its own 10-year median of 220.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Shanghai Obio Technology (Group) stock overvalued right now?
Based on GuruFocus' analysis, Shanghai Obio Technology (Group) (SHSE:688238) is currently considered Fairly Valued. The stock's GF Value™ is ¥7.39, compared to a current price of ¥6.86 — trading 7.2% below its estimated fair value. The current Days Payable is 85.56, which is 61% below median its 10-year median of 220.06 and 23% below the Biotechnology industry median of 111.17. Shanghai Obio Technology (Group)'s overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Shanghai Obio Technology (Group) (SHSE:688238), the current Days Payable is 85.56 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Shanghai Obio Technology (Group) (SHSE:688238) Overvalued in 2026?
Based on GuruFocus' analysis, Shanghai Obio Technology (Group) stock appears to be undervalued.
The current stock price of ¥6.86 is trading 7.2% below its estimated GF Value™ of ¥7.39.
GuruFocus considers Shanghai Obio Technology (Group) to be Fairly Valued.
Key valuation signals for SHSE:688238:
Days Payable: 85.56 (61% below median its 10-year median of 220.06)
GF Value™: ¥7.39 vs. price of ¥6.86 (7.2% below fair value)
Industry Position: 23% below the Biotechnology median (#362 of 708)
No single metric tells the full story. See the SHSE:688238 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Shanghai Obio Technology (Group) Corp Ltd provides contract research organization (CRO) services, including gene therapy vector development and gene function research for basic research, as well as contract development and manufacturing organization (CDMO) services, including IND-enabling CMC research and GMP production of clinical samples for gene therapy drug development.
70GF Score
Get the complete analysis for SHSE:688238
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688238 has been successfully added to your 
